These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34491469)

  • 1. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
    Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
    Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
    Li Y; Tao L; Zuo Z; Zhou Y; Qian X; Lin Y; Jie H; Liu C; Li Z; Zhang H; Zhang H; Cen X; Yang S; Zhao Y
    Cancer Lett; 2019 Jul; 454():179-190. PubMed ID: 30978443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Li Y; Qian X; Lin Y; Tao L; Zuo Z; Zhang H; Yang S; Cen X; Zhao Y
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer.
    Peng W; Zhang H; Tan S; Li Y; Zhou Y; Wang L; Liu C; Li Q; Cen X; Yang S; Zhao Y
    Ther Adv Med Oncol; 2020; 12():1758835920937428. PubMed ID: 32754230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
    Liu S; Lu W; Li S; Li S; Liu J; Xing Y; Zhang S; Zhou JZ; Xing H; Xu Y; Rao Q; Deng C; Wang M; Wang J
    Oncotarget; 2017 May; 8(19):31901-31914. PubMed ID: 28404874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
    Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN
    Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
    Sang N; Zhong X; Gou K; Liu H; Xu J; Zhou Y; Zhou X; Liu Y; Chen Z; Zhou Y; Li Y; Tao L; Su N; Zhou L; Qiu J; Yang X; Zuo Z; Fu L; Zhang J; Li D; Li C; Sun Q; Lei J; Li R; Yang S; Cen X; Zhao Y
    MedComm (2020); 2023 Jun; 4(3):e269. PubMed ID: 37250145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex.
    Dai YH; Hung LY; Chen RY; Lai CH; Chang KC
    Transl Res; 2016 Sep; 175():129-143.e13. PubMed ID: 27150054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect.
    Etani T; Suzuki T; Naiki T; Naiki-Ito A; Ando R; Iida K; Kawai N; Tozawa K; Miyata N; Kohri K; Takahashi S
    Oncotarget; 2015 Feb; 6(5):2865-78. PubMed ID: 25605246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma.
    Liu J; Chang YT; Kou YY; Zhang PP; Dong QL; Guo RY; Liu LY; Lin HW; Yang F
    Med Oncol; 2024 Jul; 41(9):212. PubMed ID: 39073639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
    Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
    Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
    Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway.
    Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J
    BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma.
    Zhang XT; Hu XB; Wang HL; Kan WJ; Xu L; Wang ZJ; Xiang YQ; Wu WB; Feng B; Li JN; Gao AH; Dong TC; Xia CM; Zhou YB; Li J
    Acta Pharmacol Sin; 2021 May; 42(5):814-823. PubMed ID: 32855532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
    Theisen ER; Gajiwala S; Bearss J; Sorna V; Sharma S; Janat-Amsbury M
    BMC Cancer; 2014 Oct; 14():752. PubMed ID: 25300887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.
    Shi JQ; Lasky K; Shinde V; Stringer B; Qian MG; Liao D; Liu R; Driscoll D; Nestor MT; Amidon BS; Rao Y; Duffey MO; Manfredi MG; Vos TJ; D' Amore N; Hyer ML
    Mol Cancer Ther; 2012 Sep; 11(9):2045-53. PubMed ID: 22609854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.
    He Y; Li J; Ding N; Wang X; Deng L; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Song Y; Zhu J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):86. PubMed ID: 30777096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
    Chen Y; Johnson JD; Jayamohan S; He Y; Venkata PP; Jamwal D; Alejo S; Zou Y; Lai Z; Viswanadhapalli S; Vadlamudi RK; Kost E; Sareddy GR
    Mol Carcinog; 2024 Oct; 63(10):2026-2039. PubMed ID: 38990091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.